Poorly perfused tumor regions harbor T cells with a glucose-dependent effector phenotype
Effector T lymphocytes are avid nutrient consumers, but can function in nutrient-poor tumor microenvironments. Availability of key nutrients such as glucose inside the tumor is not homogeneous, and how tumor-infiltrating T lymphocytes (TILs) differ between regions with better and poorer blood perfusion is not well known. Here we show that in vitro-stimulated TILs can induce substantial production of hallmark glucose-dependent cytokines under glucose concentrations 20 times lower than in blood. In vivo, effector TILs in tumor regions with poor access to blood show comparable capacity for inducing IFNγ and granzyme B to TILs with fuller accessibility; exhibit an enhanced type I IFN response supported by local myeloid cells; and unexpectedly, have reduced expression of immune checkpoint and Treg-associated markers. TILs with poor blood accessibility also have lower biosynthetic activity than highly blood-accessible TILs, yet both compartments depend fundamentally on glucose for ATP production. Thus, effector T lymphocytes in poorly perfused tumor regions can maintain specific glucose-dependent responses, and might be partially protected from inhibitory and exhausting pressure from the tumor microenvironment.
Authors
- Donata Martinuzzi (ORCID: https://orcid.org/0009-0001-4780-7456)
- Marta Riera-Borrull (ORCID: https://orcid.org/0000-0003-4670-7290)
- Andrea Cerutti (ORCID: https://orcid.org/0000-0003-3026-4704)
- Diego Ceacero‐Heras (ORCID: https://orcid.org/0000-0003-1048-5905)
- Mauricio Guzmán (ORCID: https://orcid.org/0000-0002-4447-2064)
- Sonia Tejedor Vaquero (ORCID: https://orcid.org/0000-0003-2873-4981)
- Cristina López-Rodrı́guez (ORCID: https://orcid.org/0000-0002-2311-2406)
- Claudia Tomaselli González
- Víctor Cerdán Porqueras (ORCID: https://orcid.org/0000-0002-3711-0057)
- Jose Aramburu (ORCID: https://orcid.org/0000-0001-9279-9523)
Institutions
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Universitat Pompeu Fabra (ES)
- Hospital Del Mar (ES)
- Grupo Español de Tumores Neuroendocrinos (ES)
Publication Details
- Journal
- EMBO Reports
- Published
- 2026-05-27
- DOI
- https://doi.org/10.1038/s44319-026-00799-0
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Worldwide Cancer Research
- Universitat Pompeu Fabra
- Generalitat de Catalunya
- Ministerio de Economía y Competitividad
- Institució Catalana de Recerca i Estudis Avançats
- Ministerio de Ciencia e Innovación
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- European Regional Development Fund
- Agencia Estatal de Investigación
- Ministerio de Universidades